Anika Therapeutics (ANIK)'s 30-day implied volatility (IV30) was 45.7% at the close on November 10, 2026, up from 43.2% the day before, against a 52-week range of 26.7% to 53.1%. Its 20-day historical volatility was 48.4%.
Data as of November 10, 2026.